Scleroderma is a heterogeneous autoimmune connective tissue disorder characterized by fibrosis, vascular abnormalities, and immune system dysregulation. It manifests in localized or systemic forms, affecting the skin, internal organs, and microvasculature.

The Regentime stem cell treatment offers immunomodulatory and regenerative properties: stem cells secrete cytokines and growth factors that regulate immune responses and promote tissue repair.

The Regentime procedure for scleroderma requires a stay of 5 days in Lebanon, with prices ranging from 14,000 USD to 21,000 USD.